Results: 25
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 749, doi. 10.1007/s11060-023-04470-9
- By:
- Publication type:
- Article
Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 701, doi. 10.1007/s11060-023-04469-2
- By:
- Publication type:
- Article
The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 741, doi. 10.1007/s11060-023-04468-3
- By:
- Publication type:
- Article
Characterizing T-cell dysfunction and exclusion signatures in malignant peripheral nerve sheath tumors reveals susceptibilities to immunotherapy.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 693, doi. 10.1007/s11060-023-04467-4
- By:
- Publication type:
- Article
Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 683, doi. 10.1007/s11060-023-04464-7
- By:
- Publication type:
- Article
Advancing personalized prognosis in atypical and anaplastic meningiomas through interpretable machine learning models.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 671, doi. 10.1007/s11060-023-04463-8
- By:
- Publication type:
- Article
RAI-measured frailty predicts non-home discharge following metastatic brain tumor resection: national inpatient sample analysis of 20,185 patients.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 663, doi. 10.1007/s11060-023-04461-w
- By:
- Publication type:
- Article
Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 655, doi. 10.1007/s11060-023-04460-x
- By:
- Publication type:
- Article
Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 757, doi. 10.1007/s11060-023-04457-6
- By:
- Publication type:
- Article
Treatment outcomes for response-based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 643, doi. 10.1007/s11060-023-04453-w
- By:
- Publication type:
- Article
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 729, doi. 10.1007/s11060-023-04452-x
- By:
- Publication type:
- Article
Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 545, doi. 10.1007/s11060-023-04450-z
- By:
- Publication type:
- Article
Age and sex disparities in Latin-American adults with gliomas: a systematic review and meta-analysis.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 535, doi. 10.1007/s11060-023-04448-7
- By:
- Publication type:
- Article
Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 633, doi. 10.1007/s11060-023-04447-8
- By:
- Publication type:
- Article
Seizure outcomes after resection of primary brain tumors in pediatric patients: a systematic review and meta-analysis.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 525, doi. 10.1007/s11060-023-04446-9
- By:
- Publication type:
- Article
Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 617, doi. 10.1007/s11060-023-04445-w
- By:
- Publication type:
- Article
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 607, doi. 10.1007/s11060-023-04444-x
- By:
- Publication type:
- Article
Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 505, doi. 10.1007/s11060-023-04441-0
- By:
- Publication type:
- Article
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 597, doi. 10.1007/s11060-023-04440-1
- By:
- Publication type:
- Article
The impact of opioid administration for post gamma knife radiosurgery frame removal: a prospective quality-improvement study.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 721, doi. 10.1007/s11060-023-04436-x
- By:
- Publication type:
- Article
Long-term clinical outcomes of stereotactic radiotherapy for bilateral vestibular schwannomas in neurofibromatosis type 2 patients.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 587, doi. 10.1007/s11060-023-04430-3
- By:
- Publication type:
- Article
Correction to: MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Sexually dimorphic effect of H-ferritin genetic manipulation on survival and tumor microenvironment in a mouse model of glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 569, doi. 10.1007/s11060-023-04415-2
- By:
- Publication type:
- Article
Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 711, doi. 10.1007/s11060-023-04414-3
- By:
- Publication type:
- Article
Supramaximal resection based on en-bloc technique reduces tumor burden and prolongs survival in primary supratentorial lobar glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 557, doi. 10.1007/s11060-023-04399-z
- By:
- Publication type:
- Article